Health
ACE2 agonist C21 relieves respiratory difficulty in COVID-19 – News-Medical.Net
A new study describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting enzyme 2 (ACE2), the host…
The advent of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to over 2.2 million deaths over a period of just over a year. The lack of effective drugs to combat the virus has led to intensive research to identify preventive and therapeutic antivirals.
A new preprint on the medRxiv* server describes a pilot study on the efficacy of a molecule called C21, which enhances the activity of the angiotensin-converting…
-
General19 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General17 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News20 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General5 hours agoByford rail extension opening marks final stage of Perth Metronet